Kearney Terrence C bought VRTX
May 1, 2024 · Form 4 insider transaction
Kearney Terrence C bought 3,142 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,142
Price
$0.00
Total value
N/A
InsiderKearney Terrence C
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 1, 2024
Filing dateMay 3, 2024
Shares owned after3,142
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Fully vested.